0001562180-20-007081.txt : 20201204 0001562180-20-007081.hdr.sgml : 20201204 20201204164853 ACCESSION NUMBER: 0001562180-20-007081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201202 FILED AS OF DATE: 20201204 DATE AS OF CHANGE: 20201204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith-Farrell Joanne CENTRAL INDEX KEY: 0001304048 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 201370402 MAIL ADDRESS: STREET 1: 60 BINNEY STREET STREET 2: C/O BLUEBIRD BIO, INC. CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-12-02 false 0001293971 bluebird bio, Inc. BLUE 0001304048 Smith-Farrell Joanne C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 false true false false COO, Oncology Common Stock 2020-12-02 4 S false 37.00 46.1895 D 21939.00 D Common Stock 2020-12-02 4 S false 1.00 46.50 D 21938.00 D Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. The range in prices for the transaction reported on this line was $45.48 to $46.37. The average weighted price was $46.1895. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Helen C. Fu, Attorney-in-Fact 2020-12-04